These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8045917

  • 21. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Kahán Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K, Halmos G.
    Cancer; 2000 Mar 15; 88(6):1384-92. PubMed ID: 10717621
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.
    Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ.
    Eur J Cancer; 1998 Apr 15; 34(5):710-7. PubMed ID: 9713279
    [Abstract] [Full Text] [Related]

  • 23. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.
    Clin Cancer Res; 2005 Jan 01; 11(1):49-57. PubMed ID: 15671527
    [Abstract] [Full Text] [Related]

  • 24. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M.
    Prostate; 2005 Aug 01; 64(3):303-15. PubMed ID: 15754342
    [Abstract] [Full Text] [Related]

  • 25. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.
    Pinski J, Halmos G, Schally AV.
    Cancer Lett; 1993 Jul 30; 71(1-3):189-96. PubMed ID: 8103419
    [Abstract] [Full Text] [Related]

  • 26. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K, Schally AV, Groot K, Halmos G.
    Int J Cancer; 1993 May 08; 54(2):282-9. PubMed ID: 8387464
    [Abstract] [Full Text] [Related]

  • 27. Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
    Szepeshazi K, Schally AV, Rick FG, Block NL, Vidaurre I, Halmos G, Szalontay L.
    Anticancer Drugs; 2012 Oct 08; 23(9):906-13. PubMed ID: 22926257
    [Abstract] [Full Text] [Related]

  • 28. Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
    Bajo AM, Schally AV, Krupa M, Hebert F, Groot K, Szepeshazi K.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3836-41. PubMed ID: 11891317
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR, Radulovic S, Groot K, Schally AV.
    Prostate; 1992 Mar 19; 20(4):269-80. PubMed ID: 1376910
    [Abstract] [Full Text] [Related]

  • 30. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
    Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F.
    Cell Cycle; 2012 Jul 01; 11(13):2518-25. PubMed ID: 22751419
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Chatzistamou I, Schally AV, Szepeshazi K, Groot K, Hebert F, Arencibia JM.
    Cancer Lett; 2001 Sep 28; 171(1):37-45. PubMed ID: 11485826
    [Abstract] [Full Text] [Related]

  • 32. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.
    Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S.
    J Natl Cancer Inst; 1992 Dec 16; 84(24):1915-22. PubMed ID: 1460673
    [Abstract] [Full Text] [Related]

  • 33. Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.
    Bajo AM, Schally AV, Groot K, Szepeshazi K.
    Br J Cancer; 2004 Jan 12; 90(1):245-52. PubMed ID: 14710236
    [Abstract] [Full Text] [Related]

  • 34. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S, Spindel ER, Rubin NH, Singh P.
    Cell Growth Differ; 1992 Feb 12; 3(2):111-8. PubMed ID: 1323998
    [Abstract] [Full Text] [Related]

  • 35. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY, Schonbrunn A.
    Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345
    [Abstract] [Full Text] [Related]

  • 36. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S, Guo YS, Townsend CM, Singh P.
    Cancer Res; 1990 Nov 01; 50(21):6772-8. PubMed ID: 2208141
    [Abstract] [Full Text] [Related]

  • 37. The binding of bombesin and somatostatin and their analogs to human colon cancers.
    Radulovic SS, Milovanovic SR, Cai RZ, Schally AV.
    Proc Soc Exp Biol Med; 1992 Jul 01; 200(3):394-401. PubMed ID: 1352046
    [Abstract] [Full Text] [Related]

  • 38. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Pinski J, Halmos G, Szepeshazi K, Schally AV.
    Cancer; 1993 Dec 01; 72(11):3263-70. PubMed ID: 8242552
    [Abstract] [Full Text] [Related]

  • 39. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
    Amiot F, Leiber D, Marc S, Harbon S.
    Am J Physiol; 1993 Dec 01; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
    [Abstract] [Full Text] [Related]

  • 40. A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.
    Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K, Horvath JE.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10913-8. PubMed ID: 9380734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.